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Abstract
Background: The influenza A virus subtypes H1N1, H1N2 and H3N2 are the most prevalent subtypes in swine. In
2003, a reassorted H1N2 swine influenza virus (SIV) subtype appeared and became prevalent in Denmark. In the
present study, the reassortant H1N2 subtype was characterised genetically and the infection dynamics compared to
an “avian-like” H1N1 virus by an experimental infection study.
Methods: Sequence analyses were performed of the H1N2 virus. Two groups of pigs were inoculated with the
reassortant H1N2 virus and an “avian-like” H1N1 virus, respectively, followed by inoculation with the opposite
subtype four weeks later. Measurements of HI antibodies and acute phase proteins were performed. Nasal virus
excretion and virus load in lungs were determined by real-time RT-PCR.
Results: The phylogenetic analysis revealed that the reassorted H1N2 virus contained a European “avian-like”
H1-gene and a European “swine-like” N2-gene, thus being genetically distinct from most H1N2 viruses circulating in
Europe, but similar to viruses reported in 2009/2010 in Sweden and Italy. Sequence analyses of the internal genes
revealed that the reassortment probably arose between circulating Danish “avian-like” H1N1 and H3N2 SIVs.
Infected pigs developed cross-reactive antibodies, and increased levels of acute phase proteins after inoculations.
Pigs inoculated with H1N2 exhibited nasal virus excretion for seven days, peaking day 1 after inoculation two days
earlier than H1N1 infected pigs and at a six times higher level. The difference, however, was not statistically
significant. Pigs euthanized on day 4 after inoculation, had a high virus load in all lung lobes. After the second
inoculation, the nasal virus excretion was minimal. There were no clinical sign except elevated body temperature
under the experimental conditions.
Conclusions: The “avian-like” H1N2 subtype, which has been established in the Danish pig population at least since
2003, is a reassortant between circulating swine “avian-like” H1N1 and H3N2. The Danish H1N2 has an “avian-like”
H1 and differs from most other reported H1N2 viruses in Europe and North America/Asia, which have H1-genes of
human or “classical-swine” origin, respectively. The variant seems, however, also to be circulating in countries like
Sweden and Italy. The infection dynamics of the reassorted “avian-like” H1N2 is similar to the older “avian-like” H1N1
subtype.
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Introduction
Influenza A virus is a common cause of respiratory disease
in swine. The virus also infects other species including
humans and birds. Influenza A viruses are classified into
different subtypes based on the surface glycoproteins
hemagglutinin (HA) and neuraminidase (NA). So far, 17
different HA and 10 different NA subtypes have been
described [1-4]. The predominant swine influenza virus
(SIV) subtypes worldwide are H1N1, H1N2 and H3N2, all
of which show considerable diversity within each subtype.
Until the emergence of the pandemic influenza A (H1N1)
2009 (H1N1pdm09) virus, which possesses a “classical-
swine” H1 HA gene, the European H1N1 SIV belonged
exclusively to the “avian-like” lineage of SIV with all eight
gene segments of avian origin [5] or they were reassortants
hereof retaining the “avian-like” H1 HA. European
H3N2 SIV are human-avian reassortants retaining the
HA and NA genes from human H3N2 virus, whereas
the remaining gene segments originate from “avian-like”
H1N1 SIV [6]. H1N2, which is the most recently recog-
nized new European SIV subtype, was first reported
from Great Britain in 1995 [7]. This virus possessed an
HA closely related to that of human A/England/80-like
H1N1 viruses, an NA probably derived from a swine
H3N2 virus, and internal gene segments of avian origin
[8]. Subsequent spread of related “human-like” H1N2
viruses has been reported from several European coun-
tries (Italy and France [9], Belgium [10], Germany [11]
and Spain [12]) including reassortments containing HA
from the “human-like” H1N2 [13]. “Human-like” H1N2
viruses (so-called delta clade viruses) have also been
reported from North America [14] but other H1N2
viruses that are circulating in North America and Asia
[15-19] contain HA genes of “classical-swine” H1N1
origin descending from the very first SIVs, which were
isolated from pigs in USA in 1930 [20] and resemble
human viruses responsible for the 1918 Spanish flu
pandemic. Since the emergence of the H1N1pdm09
virus in swine, several descendant reassortant viruses
have been recognized, including H1N2 with all genes
from the pandemic virus except the N2 [21] and an
H1N2 with HA and NA from the “human-like” swine
H1N2 and the rest of the genes from H1N1pdm09 virus
[22]. H1N2 viruses with “avian-like” H1 have earlier
been reported from France and Italy [9,23], but without
having been established in the regional pig populations.
In Denmark, the H1N2 subtype was first recognized in
a lung tissue sample from a pig with coughing, fever and
panting, showing indications of bronchopneumonia. This
pig was submitted to the National Veterinary Institute for
diagnosis of SIV in 2003. The detected virus (A/swine/
Denmark/12687/2003(H1N2) had an “avian-like” H1, and
this reassorted H1N2 subtype has since then continu-
ously been detected from lung tissue and nasal swabs
from Danish pigs throughout the country, and is now
established in Denmark (unpublished data). Prior to 2003,
only the H1N1 and H3N2 subtypes had been isolated in
Denmark [24]. The “avian-like” H1N2 has been reported
previously from Sweden and Italy [25-27]. The aim of the
present study was to make a genetic characterization of
the Danish reassorted “avian-like” H1N2 virus and to
compare the cross-protection and infection dynamics of
the reassorted “avian-like” H1N2 with the older endemic
“avian-like” H1N1 virus.
Results
Analysis of sequences and phylogenetics
Viruses included in the study are listed in Table 1 with
GenBank accession numbers. The phylogenetic analysis
at the nucleotide level showed that the HA of the Danish
H1N2 SIV´s was closely related to the HA gene of con-
currently circulating Danish H1N1 viruses, whereas the
NA gene was closely related to that of concurrent H3N2
viruses (Figures 1 and 2). The HA gene was of the avian-
like lineage and the identity to the concurrent Danish
H1N1 viruses was 93–96% (Table 2). The identity of the
HA gene between the Danish H1N2 viruses and the refer-
ence virus A/swine/Scotland/410440/1994(H1N2) as well
as contemporary European human-like H1N2 viruses
from Germany were ~73%. The NA gene of the Danish
H1N2 viruses clustered phylogenetically with concurrent
Danish H3N2 viruses with an identity between 91–99%
(Table 2). The nucleotide sequence comparisons of all
gene segments are shown in Table 3 and phylogenetic
trees for the internal genes are shown in Figure 3. The
nucleotide sequences of the internal genes of two H1N2
isolates were determined and they showed a high degree
of identity with those of either the H1N1 and/or H3N2
Danish contemporary SIV isolates (93–99% nucleotide
identity). The comparisons also revealed that A/swine/
Denmark/13608/2004(H1N2) had more genes with high
identity to A/swine/Denmark/14348-9/2003(H3N2) than
to A/swine/Denmark/14348-3/2003(H1N1), whereas A/
swine/Denmark/12687/2003(H1N2) was more identical
to A/swine/Denmark/14348-3/2003(H1N1). The phy-
logenetic analyses (Figure 1, 2, and 3) supported two
clusters represented by A/swine/Denmark/13608/2004
(H1N2) and A/swine/Denmark/12687/2003(H1N2), re-
spectively. In general the internal genes of the Danish
reassortant H1N2 viruses clustered phylogenetically
with European viruses and separated from American
“classical-swine” H1 and H1pdm09 virus strains. In all
gene segments, A/swine/Denmark/13608/2004(H1N2)
had a very high nucleotide identity (HA gene ~96%, NA
gene ~96%) to H1N2 reassortant viruses detected in
Sweden and Italy in 2009 and 2010 (Table 2) containing
avian-like H1 and N2 from H3N2 SIV, and they group
closely together in the phylogenetic trees. At the amino
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acid level, seven N-glycosylation sites (positions 28, 40,
71, 179, 291, 498, 557) were predicted for A/swine/
Denmark/13608/2004(H1N2) in the HA protein, whereas
only 4 sites (positions 28, 40, 498, 557) were predicted
in A/swine/Denmark/12687/2003(H1N2). The Italian
A/swine Italy/58769/2010(H1N2) had conserved glyco-
sylation sites similar to A/swine/Denmark/13608/2004
(H1N2), but had an additional predicted site at position
212. The Swedish viruses showed all the predicted
glycosylation sites of the A/swine/Denmark/13608/2004
(H1N2) virus except for 71 or 179 in 2010 and 2009,
respectively. In the receptor binding domain of the HA
protein, all Danish H1 viruses as well as the Swedish
and Italian viruses had a D in position 190. In position
225, A/swine/Denmark/13608/2004(H1N2) and the Italian
virus had K, whereas the A/swine/Denmark/12687/2003
(H1N2) had an E. The Swedish viruses had a 225 T
motif similar to the Danish A/swine/Denmark/13411/
2004(H1N2) and A/swine/Denmark/13880/2004(H1N2)
viruses. The NA sequences of the Danish H1N2 viruses
showed no indication of resistance to NA-inhibitors,
whereas all the Danish M sequences deduced resistance
against amantadine.
Clinical signs and gross pathology
There were few visible clinical signs during the experi-
ment in both groups. After the first inoculation at post
inoculation day (PID) 0, an increase in body temperature
seen on PID 1 in most of the pigs inoculated with H1N2
returned to normal level on PID 2 (Figure 4). After the
second inoculation on PID 28, elevated body temperatures
could not be observed (Figure 4).
Pigs inoculated with H1N1 on PID 0 and euthanized
on day 4 (group 1) had consolidated lobules in the cranial
lung lobes. In the left cranial lobe and middle lobe, the
consolidated areas constituted <10% of the lobes. H1N2
inoculated pigs euthanized on PID 4 (group 2), had more
widespread consolidations in the lung lobes compared to
the pigs in group 1. In the left cranial lobes, approximately
80% of the tissue was consolidated, the middle lobes were
Table 1 Viruses included in the study
Virus Subtype Passage history Sample material GenBank accession no.
A/swine/Denmark/12231-1/2005(H1N2) H1N2 none Lung KC900232
A/swine/Denmark/10074/2004(H1N2) H1N2 3MDCK Lung KC900233, KC900234
A/swine/Denmark/10044/2004(H1N2) H1N2 2MDCK Lung KC900235, KC900236
A/swine/Denmark/10501//2004(H1N2) H1N2 4MDCK Lung KC900237, KC900238
A/swine/Denmark/13411/2004(H1N2) H1N2 2SK Lung KC900249, KC900250
A/swine/Denmark/13380/2004(H1N2) H1N2 1SK Lung KC900251, KC900252
A/swine/Denmark/13608/2004(H1N2) H1N2 1SK Lung KC900253 to KC900260
A/swine/Denmark/12687/2003(H1N2) H1N2 4SK Lung KC900261 to KC900268
A/swine/Denmark/13991/2003(H3N2) H3N2 3SK Lung KC900239
A/swine/Denmark/10210/2005(H3N2) H3N2 1SK Lung KC900240
A/swine/Denmark/14348-9/2003(H3N2) H3N2 1SK NS KC900241 to KC900248
A/swine/Denmark/14738-1/2003(H1N1) H1N1 4MDCK Lung KC900269
A/swine/Denmark/13184-1/2004(H1N1) H1N1 1SK Lung KC900270
A/swine/Denmark/12813-1/2004(H1N1) H1N1 1SK Lung KC900271
A/swine/Denmark/14348-3/2003(H1N1) H1N1 1SK Lung KC900272 to KC900279
A/swine/Denmark/12245/2004(H1N1) H1N1 1SK Lung KC900280
A/swine/Denmark/10404-1/2005(H1N1) H1N1 1SK Lung KC900281
A/swine/Denmark/13772-1/2003(H1N1) H1N1 2SK Lung KC900282
A/swine/Denmark/13850/2003(H1N1) H1N1 2SK Lung KC900283
A/swine/Denmark/13160-1/2004(H1N1) H1N1 2SK Lung KC900284
A/swine/Denmark/10376-1/2005(H1N1) H1N1 2SK Lung KC900285
A/swine/Denmark/10282/2004(H1N1) H1N1 2MDCK Lung KC900286
A/swine/Denmark/10361/2004(H1N1) H1N1 4MDCK Lung KC900287
A/swine/Denmark/14743-1/2003(H1N1) H1N1 3SK Lung KC900288
A/swine/Denmark/19126/1993(H1N1) H1N1 3SK Lung KC900289
Viruses included in the study with accession numbers for sequences submitted to Genbank. MDCK; Madin-Darby canine kidney cells, SK; primary swine kidney
cells, NS; nose swab.
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approximately 40% consolidated and the accessory lobes
were 20% consolidated. In the right and left caudal lobes,
consolidated areas were only evident in the most cranial
part and only a few lobules were consolidated in the right
cranial lobe. The pigs euthanized PID 56 had no gross-
pathological changes.
0.05
A/swine/Haseluenne/IDT2617/2003(H1N1)_EU163946
A/swine/Indiana/9K035/1999(H1N2)_AF250124
A/swine/Cloppenburg/IDT4777/2005(H1N2)_EU053141
A/swine/Denmark/10044/2004(H1N2)
A/swine/Italy/58769/2010(H1N2)_HM771276
A/swine/Italy/22530/2002(H1N2)_HQ658491
A/swine/IDT/Re230/92hp/1992(H1N1)_EU163947
A/swine/Italy/116114/2010(H1N2)_CY067662
A/swine/Doetlingen/IDT4735/2005(H1N2)_EU053133
A/swine/Denmark/12813-1/2004(H1N1)
A/swine/Korea/CY02/2002(H1N2)_AY129156
A/swine/England/438207/1994(H1N2)_AF085414
A/swine/Germany/SEk1178/2000(H1N2)_AM920737
A/swine/Denmark/13380/2004(H1N2)
A/swine/Sweden/9706/2010(H1N2)_HM626482
A/swine/Denmark/10404-1/2005(H1N1)
A/swine/England/00003/2009(H1N2)_CY115896
A/swine/Denmark/13608/2004(H1N2)
A/swine/Belgium/1/1983(H1N1)_AF091316
A/swine/Denmark/WVL9/1993(H1N1)_CY038023
A/swine/Sweden/1021/2009(H1N2)_GQ495132
A/swine/England/1382/2010(H1N2)_JF290391
A/swine/Iowa/930/2001(H1N2)_AF455679
A/swine/Spain/51915/2003(H1N1)_CY010572
A/swine/Denmark/10376-1/2005(H1N1)
A/swine/Alberta/OTH-33-8/2009(H1N1)_GQ150328
A/swine/Denmark/12245/2004(H1N1)
A/swine/Zhejiang/1/2004(H1N2)_DQ139320
A/swine/England/690421/1995(H1N2)_AF085415
A/swine/Denmark/14738-1/2003(H1N1)
A/swine/Spain/50047/2003(H1N1)_CY009892
A/swine/United_Kingdom/1993(H1N1)_U72668
A/swine/Denmark/13850/2003(H1N1)
A/swine/Germany/Vi5698/1995(H1N1)_AM920728
A/California/04/2009(H1N1)_FJ966082
A/swine/Denmark/10074/2004(H1N2)
A/swine/Saraburi/NIAH13021/2005(H1N2)_EU296607
A/swine/Denmark/19126(H1N1)
A/swine/Denmark/13772-1/2003(H1N1)
A/swine/Scotland/410440/1994(H1N2)_AF085413
A/swine/Denmark/10282/2004(H1N1)
A/swine/Denmark/13411/2004(H1N2)
A/swine/Denmark/10501/2004(H1N1)
A/swine/Denmark/14743-1/2003(H1N1)
A/swine/Denmark/13160-1/2004(H1N1)
A/swine/Denmark/13184-1/2004(H1N1)
A/swine/England/17394/1996(H1N2)_AF085416
A/swine/Denmark/14348-3/2003(H1N1)
A/swine/United_Kingdom/1986(H1N1)_U72666
A/swine/Denmark/12687/2003(H1N2)
A/swine/England/72685/1996(H1N2)_AF085417
A/swine/Denmark/10361/2004(H1N1)
A/swine/United_Kingdom/1992(H1N1)_U72667
A/swine/Bakum/1832/2000(H1N2)_EU053148
A/swine/Italy/671/1987(H1N1)_AF091315962
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Figure 1 Phylogenetic analysis of the HA nucleotide sequences of Danish H1N2 viruses. The tree shows the phylogenetic relationship of
the HA gene (position 1–1701) from the reassorted Danish H1N2 swine influenza virus to representative HA genes of H1 swine origin. Gene
sequences were aligned with Muscle using CLC DNA Workbench version 6.8.1. Neighbour Joining trees were calculated with a bootstrap value of
1000. Danish H1N2 sequences are in orange and Danish H1N1 sequences are in green.
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Acute phase protein measurements
The acute phase responses were included as an objective
measurement of infection severity. Results from measure-
ments of the acute phase protein C - Reactive Protein
(CRP), Serum Amyloid A (SAA) and haptoglobin are
shown in Figure 5. Both groups of pigs (group 1: H1N1
followed by H1N2, group 2: H1N2 followed by H1N1)
showed haptoglobin and CRP responses following each of
the inoculations, peaking on PID 4 and 35 (group 1) or 4
and 39 (group 2). No SAA response was seen for group 2
after the H1N2 infection, however, these pigs did show an
SAA response after the subsequent H1N1 inoculation. In
contrast, an SAA response was seen both at the first infec-
tion (H1N1) and the second infection (H1N2) for group 1.
The difference between groups for all three acute phase
proteins were not statistically significant when using an
unpaired t-test with 95% confidence interval (CRP, p = 0,4;
haptoglobin, p = 0,8; SAA, p = 0,5).
0.05
A/swine/Italy/22530/2002(H1N2)_HQ660234
A/swine/Cloppenburg/IDT4777/2005(H1N2)_EU053143
A/swine/Italy/636/1987(H3N2)_AJ293935
A/swine/Sweden/9706/2010(H1N2)_HM626484
A/swine/Denmark/14348ns9/2003(H3N2)
A/swine/Denmark/13608/2004(H1N2)
A/swine/Italy/2064/1999(H1N2)_AJ412693
A/swine/Bakum/1832/2000(H1N2)_EU053150
A/swine/Denmark/10501/2004(H1N2)
A/swine/Scotland/410440/1994(H1N2)_AJ412697
A/swine/Hong_Kong/5212/1999(H3N2)_AY363557
A/swine/Denmark/13380/2004(H1N2)
A/swine/Denmark/10074/2004(H1N2)
A/swine/Italy/1461/1996(H3N2)_AJ293936
A/swine/Illinois/100084/2001(H1N2)_AF455698
A/swine/Italy/58769/2010(H1N2)_HM771275
A/swine/Belgium/220/1992(H3N2)_AJ311455
A/swine/Doetlingen/IDT4735/2005(H1N2)_EU053135
A/swine/Denmark/10210/2005(H3N2)
A/swine/England/00003/2009(H1N2)_CY115898
A/swine/Denmark/12231-1/2005(H1N2)
A/swine/Italy/1510/1998(H3N2)_AJ293937
A/swine/Spain/39139/2002(H3N2)_CY009382
A/swine/Denmark/13411/2004(H1N2)
A/swine/Sweden/1021/2009(H1N2)_GQ495134
A/swine/Denmark/12687/2003(H1N2)
A/swine/Denmark/10044/2004(H1N2)
A/swine/Denmark/13991/2003(H3N2)
A/swine/Gent/7625/1999(H1N2)_AY590829
A/swine/Korea/CY02/2002(H1N2)_AY129157
A/swine/Indiana/9K035/1999(H1N2)_AF250126
A/swine/Italy/116114/2010(H1N2)_CY067664
A/swine/Zhejiang/1/2004(H1N2)_DQ139321
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Figure 2 Phylogenetic analysis of the NA nucleotide sequences of Danish H1N2 viruses. The tree shows the phylogenetic relationship of
the NA gene (position 22–1380) from the reassorted Danish H1N2 swine influenza virus to representative NA genes of N2 swine origin. Gene
sequences were aligned with Muscle using CLC DNA Workbench version 6.8.1. Neighbour Joining trees were calculated with a bootstrap value of
1000. Danish H1N2 sequences are in orange and Danish H3N2 sequences are in purple.
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Table 2 Percent identity at the nucleotide level for Danish SIV viruses and reference viruses
Virus 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
A/swine/Denmark/13608/2004(H1N2) 1 98 98 95 95 95 96 97 74 96 74 74 74 93 94 95 94 73 n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/13411/2004(H1N2) 2 98 100 95 95 95 97 98 73 96 74 73 74 93 94 94 94 73 n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/13380/2004(H1N2) 3 98 100 95 95 95 97 98 73 96 74 73 74 93 94 95 94 73 n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/12687/2003(H1N2) 4 92 92 92 96 96 93 94 73 93 74 73 74 94 94 95 95 73 n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/10044/2004(H1N2) 5 98 99 99 92 100 93 93 74 93 74 73 74 94 95 95 95 74 n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/10074/2004(H1N2) 6 98 99 99 92 100 93 93 74 93 74 73 74 94 95 95 95 74 n.a. n.a. n.a. n.a. n.a.
A/swine/Sweden/9706/2010(H1N2)_HM626482 7 96 98 98 90 96 96 98 73 94 73 72 74 91 92 93 92 73 n.a. n.a. n.a. n.a. n.a.
A/swine/Sweden/1021/2009(H1N2)_GQ495132 8 97 98 98 90 97 97 98 73 95 74 73 74 92 93 93 93 73 n.a. n.a. n.a. n.a. n.a.
A/swine/Italy/116114/2010(H1N2)_CY067662 9 95 96 96 90 97 97 94 94 73 77 76 95 74 73 73 74 99 n.a. n.a. n.a. n.a. n.a.
A/swine/Italy/58769/2010(H1N2)_HM771276 10 96 97 97 91 97 97 95 96 94 74 74 74 91 92 93 93 73 n.a. n.a. n.a. n.a. n.a.
A/swine/Scotland/410440/1994(H1N2)_AF085413 11 88 89 89 88 88 88 88 88 87 87 92 78 74 73 74 73 77 n.a. n.a. n.a. n.a. n.a.
A/swine/Doetlingen/IDT4735/2005(H1N2)_EU053133 12 90 90 90 90 90 90 89 89 88 89 87 77 73 73 73 73 76 n.a. n.a. n.a. n.a. n.a.
A/swine/Indiana/9 K035/1999(H1N2)_AF250124 13 86 87 87 86 87 87 86 86 85 86 89 86 75 74 74 74 95 n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/19126/1993(H1N1) 14 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 93 94 93 74 n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/12245/2004(H1N1) 15 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 94 95 73 n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/14743-1/2003(H1N1) 16 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 95 73 n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/12813-1/2004(H1N1) 17 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 74 n.a. n.a. n.a. n.a. n.a.
A/swine/Alberta/OTH-33-8/2009(H1N1pdm)_GQ150328 18 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/13991/2003(H3N2) 19 98 98 98 92 99 99 96 97 96 96 89 90 87 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
A/swine/Denmark/10210/2005(H3N2) 20 98 98 98 91 99 99 96 97 96 96 88 90 86 n.a. n.a. n.a. n.a. n.a. 99 n.a. n.a. n.a.
A/swine/Denmark/14348 ns9/2003(H3N2) 21 98 99 99 92 99 99 96 97 96 97 89 90 87 n.a. n.a. n.a. n.a. n.a. 99 99 n.a. n.a.
A/swine/Spain/39139/2002(H3N2)_CY009382 22 90 91 91 91 90 90 89 89 88 89 87 94 85 n.a. n.a. n.a. n.a. n.a. 90 90 90 n.a.
A/swine/Hong Kong/5212/1999(H3N2)_AY363557 23 93 94 94 95 93 93 92 92 91 92 89 92 87 n.a. n.a. n.a. n.a. n.a. 93 93 94 92
Percent identity at the nucleotide level for Danish SIV viruses and reference SIV viruses calculated for the HA and NA gene. Lower part of the table is between N2 sequences and upper part of the table is between H1
sequences, n.a.; not applicable.
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Antibody detection
The results of the HI-test after 1st and 2nd inoculations are
shown in Figure 6. For both groups of pigs an antibody re-
sponse against the homologue HI-test antigen was elicited
after the first inoculation and after second inoculation
with the other virus (heterologous to the HI-test antigen)
a boost in the antibody response was seen for group 1
pigs. This was not clearly observed for group 2 pigs. In
contrast, no or very low titres of HI antibodies were seen
after the first inoculation when the heterologous virus was
used as antigen, however after the second inoculations,
antibody responses were seen in both groups.
Measurement of nasal virus excretion and virus load in
the lung by real time RT-PCR
The results of the real time RT-PCR screening are
shown for the nasal swab samples in Table 4. In general,
influenza A virus RNA was detected in nasal swabs in
both groups until day 7 after the 1st inoculation. After
the 2nd inoculation on day 28, the pigs were negative by
this assay, except for two pigs in group 2 that were posi-
tive on day 29 and 35 and only day 35, respectively.
Virus was detected with the screening assay in all nine
lung samples from pigs euthanized on day 4 but not
from pigs euthanized on day 56.
The results of the quantitative real time RT-PCR assay
on the positive samples showed virus excretions from
PID 1 to PID 6–8 (Figure 7). For the pigs in group 1
(H1N1 inoculated), the virus titre peaked with an average
of 5.8 × 106 TCID50 equivalents on PID 3. For the pigs in
group 2 (H1N2 inoculated), the peak was approximately 6
times higher reaching 3.6 × 107 TCID50 equivalents PID
1. In group 2, two nasal swabs from one pig were found to
be positive with a virus load of 5.6 × 102 TCID50 equiva-
lents on PID 29 and 1.9 × 102 TCID50 equivalents on PID
35. A second pig in group 2 was positive on PID 35 with a
titre of 1.1 × 103 TCID50 equivalents. The difference in
nasal virus excretion between groups was not significant
with a p-value at 0.06 in unpaired t-test with a 95% confi-
dence interval. Virus load in the lungs of pigs euthanized
on PID 4 varied between 104 and 109 TCID50 equivalents
in the different lung sections (Table 5). Furthermore, the
amount of virus in the different areas of the lungs varied
between the pigs. The average virus load of the nine lung
sections for pigs in groups 1 and 2 were 1.77 × 108
TCID50 equivalents and 2.58 × 107 TCID50 equivalents,
respectively. Thus, the virus load was about 7-fold higher
in the group of H1N1 infected pigs compared to the
H1N2 infected pigs, however this difference was not
significant (p = 0.06).
Discussion
The Danish “avian-like” H1N2 subtype variant was shown
to harbour an HA gene of “avian-like” H1N1 SIV origin,
thus differing significantly genetically and antigenic from
the prevalent H1N2 viruses circulating in most of Europe
which have a human-like HA gene. The phylogenetic ana-
lyses showed that the genes of the reassorted H1N2 virus
had very high identity to contemporary H1N1 and H3N2
subtypes circulating in Danish pigs in 2003. Based on the
sequence analysis, the Danish H1N2 subtypes apparently
arose by two independent reassortment events. This is
sustained by the full-genome sequencing analysis which
revealed a closer relationship of the two analysed H1N2
isolates internal genes to Danish H1N1 and H3N2, re-
spectively, than to each other. It is also interesting that
all of the other sequenced Danish H1N2 viruses phylo-
genetically grouped together with A/swine/Denmark/
13608/2004(H1N2), and that A/swine/Denmark/12687/
2003(H1N2) formed a separate cluster. Interestingly,
H1N2 viruses with high sequence similarity to the Danish
H1N2 in all gene segments were recently reported
from Sweden (A/swine/Sweden/1021/2009(H1N2) and
A/swine/Sweden/9706/2010(H1N2)) and Italy (A/swine/
Italy/58769/2009(H1N2)) [25-27]. The viruses from Sweden
and Italy had the highest level of similarity to the A/swine/
Table 3 Percentage nucleotide identity between Danish subtypes for all 8 influenza A segments
Gene
segment
H1N2-13608 vs. H1N2-12687 vs. H1N2- 13608 vs. Region compared
H1N1 H3N2 H1N1 H3N2 H1N2-12687
PB2 93 93 94 94 95 709-2119
PB1 93 99 96 93 93 1-2267
PA 94 99 96 95 94 1-2151
HA 94 51 95 50 95 1-1701
NP 93 99 96 93 94 1-1497
NA 49 98 49 92 92 22-1380
M 96 99 98 96 96 1-971
NS 96 99 96 96 96 1-838
The percentage identity of nucleotide sequences were calculated with CLC DNA Workbench version 6.8.1. Highest matches are in bold.
H1N1: A/Swine/Denmark/14348lu3/2003(H1N1); H3N2: A/Swine/Denmark/14348 ns9/2003(H3N2); H1N2-12687: A/Swine/Denmark/12687/2003(H1N2);
H1N2-13608: A/Swine/Denmark/13608/2004(H1N2).
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Figure 3 (See legend on next page.)
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Denmark/13608/2004(H1N2) based on phylogeny and
amino acid markers. The A/swine/Denmark/13608/2004
(H1N2) had seven predicted glycosylation sites in the
HA-protein compared to the A/swine/Denmark/12687/
2003(H1N2) which had 4 sites. Glycosylation of the HA
protein is important for virulence and antigenic masking
of influenza A virus and could be the reason for the more
successful establishment of the A/swine/Denmark/13608/
2004(H1N2) virus [28,29]. At the receptor binding domain
of the HA-protein, a different motif at position 225 was
seen for the A/swine/Denmark/12687/2003(H1N2) com-
pared to the other H1N2 viruses confirming a difference
between the clusters. The H1N2 virus was detected in
Denmark for the first time in 2003, approximately 6–
7 years before it was found in Sweden. A publication from
2012 regarding Italian H1N2 SIV reports a retrospective
finding of the “avian-like” H1N2 in samples from 2002
[27]. Before the discovery of the Danish H1N2 subtype,
subtyping of SIV in Denmark was performed using HI-
test. The HI-test only subtypes the HA of influenza A
virus and the reassortant H1N2 virus may easily have
been missed. Thus, due to the lack of systematic surveil-
lance data in Europe at that time, the exact geographical
origin of the new H1N2 subtype cannot be documented.
Nevertheless, we speculate that the reassortment event
happened between two Danish strains of H1N2 and
H3N2 and subsequently spread to other European
countries by export of living pigs. This hypothesis is
supported by the full genome characterisation of the
new reassorted viruses which showed that all gene seg-
ments were almost identical to genes of contemporary
Danish H1N1 or H3N2 isolates. Furthermore, Denmark
has a minimal import of live pigs from other countries
which hamper introduction of new isolates. Accordingly,
Denmark is free from the “human-like” H1N2 SIV which
has been prevalent in central Europe for the last decades.
The introduction of the virus into Sweden and Italy can
be explained by the import of pigs from Denmark since
pigs are not routinely tested for SIV in connection to
export. Indeed, according to the National Association of
Pig Breeders in Italy (ANAS), the import of living swine to
Italy from Denmark is substantial. Taken together the
Danish “avian-like” H1N2 subtype may be the first H1N2
subtype established within a pig population which pos-
sesses an HA of avian-like H1N1 origin.
The emergence of reassortant viruses in swine from
concurrent circulating swine viruses occasionally occurs.
Most European H1N2 viruses are closely related to A/
swine/Scotland/4104/1994(H1N2) having an HA of hu-
man origin [9]. As an exception, A/swine/Italy/2064/1999
(H1N2) has an HA gene related to the Danish H1N2 HA
gene, and to concurrent Italian H1N1 and other European
avian-like H1N1 viruses [9]. However, the NA gene of A/
swine/Italy/2064/1999(H1N2) is closely related to NA
genes of European H1N2 viruses, contrary to the Danish
subtype which has an NA gene closer related to that of
concurrent Danish H3N2 viruses. Thus, A/swine/Italy/
2064/1999(H1N2) may be a reassortment of avian-like
H1N1 and A/swine/Scotland/4104/94(H1N2)-like viruses.
There have been no further reports on this virus, so this
reassortant virus probably was unsuccessful in becoming
established in the local and regional pig population.
(See figure on previous page.)
Figure 3 Phylogenetic analysis of the internal genes of Danish H1N2 viruses. The trees show the phylogenetic relationship of the
reassorted Danish H1N2 swine influenza virus to representative Danish SIV and reference nucleotide sequences for the M-gene (position 1–971),
NP-gene (position 1–1497), NS-gene (position 1–838), PA-gene (position 1–2151), PB1-gene (position 1–2267), and PB2-gene (position 709–2119).
Gene sequences were aligned with Muscle using CLC DNA Workbench version 6.8.1. Neighbour Joining trees were calculated with a bootstrap
value of 1000. Danish H1N2 sequences are in orange, Danish H1N1 sequences are in green, and Danish H3N2 sequences are in purple.
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Figure 4 Body temperature measurements. Body temperature measurements after first inoculation post inoculation day (PID) 0 and second
inoculation PID 28 for both group 1 and 2 pigs. The stapled lines indicates respectively first and second inoculation.
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Figure 5 Acute phase protein levels in serum. The graphs show the acute phase protein levels in the serum samples from group 1 and 2
pigs, the stapled lines indicates first and second inoculation, respectively. A: Haptoglobin, B: C - Reactive Protein (CRP), C: Serum Amyloid A (SAA).
PID: post inoculation day.
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Recently, reassortments containing genes from the
H1N1pdm09 virus have occurred i.e. an H1N2 with all
genes from the pandemic virus except the N2 [21] and
an H1N2 with HA and NA from the European swine
H1N2 and the rest of the genes from the pandemic
virus [22]. These findings further sustain the need for
continuous SIV monitoring nationally and sharing of
SIV surveillance data internationally.
Under the experimental conditions of the present
study, the “avian-like” H1N2 subtype induced more
severe macroscopic lung lesions compared to the older
“avian-like” H1N1 subtype. The virus load in the lungs
and the nasal excretions were slightly higher for the
H1N2 infected pigs, however, the difference between
groups was not statistically significant. In the pigs
euthanized PID 4, virus was present in high amounts in
most of the lung sections and did not show a predilection
for any particular lung lobe, even though the macroscopic
changes were more pronounced in the cranial parts. This
is in accordance with findings of De Vleeschauwer et al.
[30] who also were unable to demonstrate a particular
pattern in virus titres in cranial and caudal lung lobes after
A/sw/Denmark/19126/93(H1N1)
-
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Figure 6 Antibody levels in serum. A: Results from the HI-test on serum samples from the experiment using A/swine/Denmark/19126/1993
(H1N1) as antigen. B: Results from the HI-test using A/swine/Denmark/10074/2004 (H1N2) as antigen. The stapled lines indicate day of inoculation
respectively post infection day (PID) 0 and PID 28.
Table 4 Results from the real time RT-PCR screenings assay detecting the NP-gene on nasal swabs
PID Group1 Group2
1 2 3 4 5 6 7 8 9 10 11 12
−3 - - - - - - - - - - - -
0 - - - - - - - - - - - -
1 + + + + + + + + + + + +
2 + + + + + + + + + + + +
3 + + + + + + + + + + + +
4 + + + + + + + + + + + +
5 n.a. n.a. + + + + n.a. n.a. + + + +
6 n.a. n.a. + + + + n.a. n.a. + + + +
7 n.a. n.a. + + (+)´ - n.a. n.a. + (+)´ + (+)´
8 n.a. n.a. - - - - n.a. n.a. - (+)´ - -
9,11,14,18,22 n.a. n.a. - - - - n.a. n.a. - - - -
28 n.a. n.a. - - - - n.a. n.a. - - - -
29 n.a. n.a. - - - - n.a. n.a. - - - +
30,31,32,33,34 n.a. n.a. - - - - n.a. n.a. - - - -
35 n.a. n.a. - - - - n.a. n.a. - - + +
36,37,39,42,46,50,56 n.a. n.a. - - - - n.a. n.a. - - - -
Group 1 pigs (1–6) were inoculated post inoculation (PID) 0 with A/swine/Denmark/19126/1993 (H1N1) and reinoculated PID 28 with A/swine/Denmark/10074/
2004 (H1N2). Group 2 pigs (7–12) were inoculated post inoculation (PID) 0 with A/swine/Denmark/10074/2004 (H1N2) and reinoculated PID 28 with A/swine/
Denmark/19126/1993 (H1N1). +: Positive samples; -: negative samples; n.a.: not applied as pigs were euthanized PID 4; (+)´: in double testing one had a positive
ct-value.
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an H1N1 infection in pigs. Initial reports from the field in
2004 claimed that the severity and duration of clinical
signs elicited in response to the H1N2 virus was more
severe compared with the H1N1 or H3N2 viruses, respect-
ively (unpublished data). However, the results only pro-
vided a non-significant tendency for the H1N2 virus to be
more virulent than the H1N1 virus. Apparently, the pigs
elicited no clinical signs in response to experimental in-
oculation. The pigs were specific laboratory raised animals
of high sanitary status free from the majority of pathogens
known to cause disease in pigs [31]. They were kept in iso-
lation without any contact to other animals eliminating
the risk of exposure to new pathogens during the experi-
ment. Furthermore, the pigs were not exposed to the same
stress as pigs housed under field conditions and they had
plenty of room and grooming material. This is probably
the explanation for the lack of clinical signs even though
the pigs clearly were infected as revealed by a slight rise in
body temperature 1–3 days after challenge, the develop-
ment of specific SIV antibodies, and the induction of an
acute phase protein response following both the primary
and the secondary inoculations. These observations fur-
ther sustain that the clinical consequences of swine influ-
enza virus infections under field conditions are highly
dependent on management and the general health status
of the herds.
Influenza A virus was excreted nasally from the day
after inoculation until approximately PID 7 in pigs from
both infection groups following the primary inoculation.
After the second inoculation at PID 28, no or very low
levels of nasal virus excretion was detected and only for
one day which firmly indicate that there is a high level
of cross-protection between the subtypes. An antibody
response was elicited after inoculation of the first virus
isolate and the response was boosted when the pigs were
re-inoculated with the second virus isolate. Haptoglobin
and CRP responses to primary infection with H1N1 and
H1N2 were very similar. In contrast, no SSA response to
primary infection with H1N2 was seen. Pomorska-Mól
et al. [32] showed data on the induction of pig acute
phase proteins CRP, haptoglobin and SAA after single
experimental infection with a Polish “human-like” H1N2
SIV subtype and found a rapid and substantial increase
in CRP, haptoglobin, and SAA. In the present study sam-
pling was not performed at PID 2 and 3, therefore an
SAA response to the primary H1N2 infection might
have been missed. The results, however, corroborate well
the results of Pomorska-Mól et al. showing pronounced
haptogobin and CRP responses at day 4 post infection
with H1N2. Taken together, these data indicated that in-
fection with either H1N1 or H1N2 induces a high level
of cross-protection against infection with the other virus.
This was expected since the HA of the two subtypes is
of the same “avian-like” origin.
The duration of the nasal virus excretion is in
accordance with other experimental studies on SIVs
showing excretion for 4–7 days after infection [33-35].
The duration of virus excretion following the primary
H1N1 and H1N2 inoculation was comparable; how-
ever, the amount of virus excreted was approximately
six-fold higher for pigs infected with H1N2 compared
to H1N1 infected pigs. The H1N2 subtype has been
very successful in spreading and constitute now 20% of
the circulating subtypes in Danish pigs (own unpub-
lished observations). The reason for this is not known
but it’s interesting that this virus has succeeded in
spreading despite existing immunity against the H pro-
tein of the H1N1 subtypes that has been circulating in
Denmark since the mid-1980s.
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Figure 7 Nasal virus excretion. Nasal virus excretion measured
with quantitative real time RT-PCR detecting the matrix gene. Group
1 pigs were inoculated post inoculation day (PID) 0 with H1N1 and
group 2 pigs were inoculated PID 0 with H1N2 (stapled line).
Table 5 Virus load in lung samples
Lung
sections
Group 1 Group 2
Pig 1 Pig 2 Pig 7 Pig 8
Lu1 6.0 × 107 9.5 × 106 1.5 × 105 2.3 × 107
Lu2 7.1 × 106 1.4 × 109 3.1 × 107 1.8 × 108
Lu3 1.1 × 107 5.2 × 108 7.5 × 106 3.7 × 107
Lu4 2.0 × 105 7.1 × 107 3.2 × 104 4.5 × 104
Lu5 3.5 × 108 1.8 × 108 7.6 × 107 1.4 × 105
Lu6 3.8 × 106 1.5 × 107 6.2 × 106 2.1 × 105
Lu7 7.8 × 106 2.1 × 108 3.7 × 107 3.2 × 107
Lu8 9.8 × 107 4.8 × 107 7.1 × 106 2.9 × 107
Lu9 1.6 × 108 3.7 × 106 2.9 × 106 8.5 × 104
The table shows the virus load expressed as TCID50 equivalents in lung
sections of pigs euthanized post inoculation day (PID) 4 measured by
quantitative real time RT-PCR detecting the matrix gene. Group 1 pigs were
inoculated PID 0 with A/swine/Denmark/19126/1993 (H1N1) and group 2 pigs
were inoculated PID 0 with A/swine/Denmark/10074/2004 (H1N2). Lu1:
cranioventral part of the left cranial lobe; lu2: caudoventral part of the left
cranial lobe; lu3: dorsal part of the left cranial lobe; lu4: ventral part of the
right cranial lobe; lu5: middle part of the right cranial lobe; lu6: dorsal part of
the right cranial lobe; lu7: middle part of the right middle lobe; lu8: middle
part of the accessory lobe; lu9: middle part of the right caudal lobe.
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Conclusion
In conclusion, the “avian-like” H1N2 subtype has been cir-
culating in Denmark since 2003 and originated probably
by reassortment between Danish strains of “avian-like”
H1N1 and H3N2. The “avian-like” H1N2 differs from
other H1N2 subtypes in most of Europe and USA. There
are two clusters of the Danish H1N2 variant and one of
them seems to have spread to countries like Sweden and
Italy. The experimental study shows comparable infection
dynamic between the “avian-like” H1N2 and “avian-like”
H1N1 with a tendency of the H1N2 to have a slightly
larger impact on lungs. There were no clear clinical sign
except elevated body temperature under the experimental
conditions. Systemic responses to both virus subtypes
were recognised by a clear antibody and acute phase re-
sponse and there were a clear cross-protection between
the two subtypes of “avian-like” H1N2 and “avian-like”
H1N1.
Materials and methods
Viruses
Viruses were propagated in either Madin-Darby Canine
Kidney Epithelial Cells (MDCK) or primary swine kidney
cell cultures. Virus isolation was achieved from routine
diagnostic samples, nasal swabs or lung tissue samples,
sent to the Danish National Veterinary Laboratory for
routine diagnostic purposes. Details on all viruses included
in the study are summarised in Table 1.
Sequencing and phylogenetic analysis
Sequencing of the HA and NA genes was performed as
previously described by Bragstad et al. 2005 [36] and
full genome sequencing of all 8 gene segments was
performed as described in Bragstad et al. 2006 [37].
Full genome sequencing was performed on the follow-
ing virus isolates: A/swine/Denmark/13608/2004(H1N2),
A/swine/Denmark/12687/2003(H1N2), A/swine/Denmark/
14348-9/2003(H3N2), and A/swine/Denmark/14348-3/
2003(H1N1).
For phylogenetic analyses, gene sequences were aligned
with MUSCLE using CLC DNA Workbench version 6.8.1.
Neighbour Joining trees were calculated with a bootstrap
value of 1000.
Amino acid sequences were deduced from nucleotide
sequences using CLC DNA Workbench version 6.8.1
and aligned with MUSCLE. N-glycosylation sites were
predicted with NetNGlyc 1.0 (CBS, DTU, Denmark).
Experimental infection
Landrace/Yorkshire (LY) pigs, both males and females,
two months of age and free from more than 30 known
swine pathogens including the important respiratory
pathogens porcine circovirus 2 (PCV2), porcine repro-
ductive and respiratory syndrome virus (PRRSV), swine
influenza virus (SIV), porcine respiratory coronavirus,
Actinobacillus pleuropneumonia and mycoplasmas [31],
were used for the experiment. The pigs were randomly
divided into two groups of 6 pigs, denoted group 1 and
group 2. Each group was housed in separate isolation
units (biosafety level 3). The pigs in group 1 were inocu-
lated intranasally in the left nostril on PID 0 with 4 ml
of A/swine/Denmark/19126/1993 (H1N1) with a titer of
105.7 tissue culture infectious dose 50% (TCID50) per
ml. Two pigs were euthanized on PID 4. On PID 28, the
remaining four pigs were re-inoculated with 4 ml of A/
swine/Denmark/10074/2004 (H1N2) with a titer of 105.9
TCID50 per ml and they were euthanized on PID 56.
For the pigs in group 2, the experimental design was
similar except that the pigs were inoculated on PID 0
with the H1N2 isolate and then on PID 28 with the
H1N1 isolate. Euthanization was performed by intraven-
ous injection of pentobarbiturate (50 mg/kg) followed by
exsanguination by cutting the arteria axillaris.
Body temperature was measured rectally before further
handling of the pigs on PID −3, 0–9, and 28–37. Clinical
signs and well-being of the pigs was monitored twice
daily during the experiment. Blood samples were taken
on PID −3, 0, 7, 11, 14, 18, 22, 28, 35, 39, 42, 46, 50, and
56 from vena jugulars from all pigs and from animals
when euthanized on PID 4. Blood samples obtained on
PID 0 and 28 were collected prior to inoculation. The
blood samples were left on ice to coagulate for 15 minutes
and centrifuged at 3500 rpm for 10 minutes at 4°C. Sera
were transferred to new vials and stored at −80°C.
Nasal swab samples were collected on PID −3, 0–9,
11, 14, 18, 22, 28–37, 39, 42, 46, 50, and 56 from the
right nostril. The swabs were placed in 1 ml phosphate
buffered saline (PBS) (pH 7.5) and stored at −80°C until
analysis. Nasal swabs taken on PID 0 and 28 were col-
lected prior to inoculation. At post mortem, samples
were collected and frozen at −80°C from the following
nine parts of the lung, lu1: cranioventral part of the left
cranial lobe; lu2: caudoventral part of the left cranial
lobe; lu3: dorsal part of the left cranial lobe; lu4: ventral
part of the right cranial lobe; lu5: middle part of the
right cranial lobe; lu6: dorsal part of the right cranial
lobe; lu7: middle part of the right middle lobe; lu8: mid-
dle part of the accessory lobe; and lu9: middle part of
the right caudal lobe.
The study was carried out in strict accordance with the
Danish legislation on animal experiments (LBK nr 1306 –
23/11/2007) and EU regulations on the use of laboratory
animals for research.
Acute phase proteins
Haptoglobin concentrations were determined by a sand-
wich ELISA as described previously [38]. The detection
limit was 66 μg/ml.
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A commercially available sandwich ELISA assay (Phase
SAA assay, Tridelta Development Ltd., Kildare, Ireland)
was used for determination of Serum Amyloid A (SAA)
concentrations. This assay was based on anti-human
monoclonal antibodies in a sandwich set-up as originally
described by McDonald et al. [39]. The detection limit
of the assay was 125 μg/ml (porcine SAA equivalents).
C – Reactive Protein (CRP) was analyzed by a sand-
wich type ELISA using dendrimer-coupled cytidine
diphosphocholine (a CRP-binding ligand) in the coating
layer as previously described [40] employing polyclonal
rabbit anti-human antibodies with cross-reactivity to-
wards porcine CRP followed by peroxidase-conjugated
goat anti rabbit antibody for detection (both antibodies
from DAKO, Glostrup, Denmark). The cross-reactivity
of the anti human CRP antibody with porcine CRP was
demonstrated previously [41]. The detection limit was
1416 ng/mL (human equivalents).
Antibody detection
Antibodies were detected with the Hemagglutination
Inhibition (HI) – test. Serum samples were pre-treated as
follows: 100 μl of serum was inactivated at 56°C for 30
minutes. 400 μl of a 25% kaolin suspension in PBS was
added and incubated for 20 minutes at room temperature
and regularly shaken. The samples were centrifuged at
3000 rpm for 10 min, the supernatant mixed with 60 μl of
packed chicken erythrocytes and incubated with the eryth-
rocytes in a water bath at 37°C for 1 hour and regularly
shaken. Finally, the samples were centrifuged at 3000 rpm
for 10 min and the supernatant was used in the HI-test.
In the HI-test, 25 μl PBS was added to each well of a
microtitre plate, then 25 μl of the sample was added and
diluted two-fold. Then 25 μl of the antigen (4 HA units)
were added to each well. The plate was shaken for
10 sec and incubated for 1 hour at room temperature.
After incubation, 25 μl of 0.6% chicken erythrocyte dilu-
tion was added to the wells, shaken for 10 sec and incu-
bated for 30 minutes at room temperature. The HI-titre of
the serum samples was determined as the highest dilution
showing complete inhibition of agglutination.
Chicken erythrocytes were used as standard blood
cells. During testing it was noted that the H1N2 isolate
used for inoculation (A/swine/Denmark/10074/2004
(H1N2)) did not have the ability to agglutinate chicken
erythrocytes. Instead guinea pig erythrocytes were used
for this isolate. The procedure for the HI-test using
guinea pig erythrocytes was similar except that a 1% sus-
pension of erythrocytes in PBS with 0.005% gelatine was
used.
RNA purification
RNA was purified from nasal swabs and lung tissue sam-
ples with RNeasy Minikit (Qiagen, GmbH, Germany).
200 μl nasal swab sample was lysed in 400 μl RLT-buffer
containing 1% ß-mercaptoethanol while 30 mg of lung
tissue were homogenized and lysed with 600 μl RLT-
buffer containing ß-mercaptoethanol by bead-beating.
After lysis, the RNA was purified according to the kit
instructions. RNA was stored at -80°C until analysis.
RNA was extracted from all nasal swabs and lung tissue
samples and tested by a real time RT-PCR screenings
assay. All positive samples were further tested in a quan-
titative real time RT-PCR assay.
Real time RT-PCR screening assay
A previously designed general influenza A virus RT-PCR
assay with specific primers for a conserved region of the
nucleoprotein (NP) gene described by Munch et al. [42]
was modified into a real time assay using SYBR green
chemistry detection. This assay was used to screen the
nasal swabs and tissue samples for influenza A virus
specific RNA. The real time RT-PCR was performed in a
Rotor-Gene 3000 machine (Corbett Research, Australia)
in a total volume of 25 μl using the Qiagen OneStep RT-
PCR kit (Qiagen, GmbH, Germany) with 2 μl of extracted
RNA, 0.6 μM of each primer (Forward Primer MMU39
and Reverse Primer MMU19), and 6.25× SYBR green
(Invitrogen SYBR® Green I Nucleic acid stain 10000×).
The amplification temperature profile was 50°C for
30 min for reverse transcription followed by 95°C for
15 min and 45 cycles of 94°C for 20 s, 60°C for 20 s and
72°C for 30 s. This was immediately followed by a melting
point analysis: 50°C for 60 s, ramping from 50°C to 99°C
in increments of 1°C and holding for 15 s at each step.
The fluorescence signal was measured at 72°C during each
PCR cycle and at each temperature increment step during
the melting analysis. All fluorescence measurements were
analysed with the Rotor-Gene Software Version 6.0. with
non template control (NTC) threshold set at 10% and the
normalised fluorescence threshold limit set at 0.05 for
cycle threshold (Ct values) determination.
Relative quantification by real time RT-PCR
For quantification of virus load in nasal swabs and in
lung tissue a quantitative real time RT-PCR assay based
on Primer Probe Energy Transfer technology (PriProET)
targeting a conserved region of the matrix gene was used
[30,43]. The real time RT-PCR was performed in a
Rotor-Gene 3000 machine (Corbett Research, Australia)
with a total reaction volume of 25 μl using the RNA
Ultrasense™ One-Step Quantitative RT-PCR System
(Invitrogen), 5 μl of extracted RNA, 0.4 μM of forward
primer, 1.0 μM of FAM-labelled reverse primer, and
1.0 μM of Cy5-labelled probe. The amplification
temperature profile was 50°C for 30 min for reverse
transcription followed by 95°C for 5 min and 45 cycles
of 95°C for 15 s, 55°C for 30 s and 72°C for 20 s and
Trebbien et al. Virology Journal 2013, 10:290 Page 14 of 16
http://www.virologyj.com/content/10/1/290
finally by 72°C for 5 min. This was immediately
followed by a melting point analysis: 95°C for 30 s,
ramping from 40°C to 99°C in increments of 1°C and
holding for 30 s at each step. The fluorescence signal
was measured at 55°C during each PCR cycle and at
each temperature increment step during the melting
analysis. Signals were generated by excitation of the
donor fluorophor (FAM) followed by collection of emis-
sion spectra from the acceptor fluorophor (Cy5). All
fluorescence measurements were analysed with the
Rotor-Gene Software Version 6.0. In each real time RT-
PCR run, RNA purified from cell cultured A/swine/
Denmark/19126/1993 (H1N1) with 103.8 TCID50 per
ml was used as positive control and RNase free water as
negative control. The NTC threshold was set at 10%
and the normalised fluorescence threshold limit at 0.02
for cycle threshold (Ct) value determination. A standard
curve for the real time RT-PCR assay was obtained using a
ten-fold dilution series made from an initial concentration
of 107.8 TCID50 per ml of the virus A/swine/Denmark/
19126/1993 (H1N1). Ct-values from samples were cali-
brated towards the standard curve to obtain a relative
quantification of TCID50 equivalents. The efficiency of
the PCR was 92% and the range of quantification spanned
6 log10 dilutions from dilution 10
-1 to 10-7.
Statistical analysis
To determine whether there was a statistical significant
difference of nasal virus excretion, virus load in lungs,
and acute phase proteins between the two groups of pigs
an un-paired t-test with a 95% confidence interval was
applied [44].
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